Evaluating the Efficacy of Cinnamunum Tamala on decreased libido , in SSRI induced sexual dysfunction(libido) in patients with neurologic and psychotic disorders

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240813062746N1

Enrollment

Registered

2024-08-21

Start date

2024-09-22

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: depression. Condition 2: adverse effect of SSRIs. Condition 3: sexual dysfunction due to taking SSRI drugs. Major depressive disorder, single episode, mild Y49.2Other and unspecified antidepressants Sedative, hypnotic, or anxiolytic related disorders

Interventions

Intervention 1: Intervention group: taking 500 mg of dried leaves of Cinnamomum Tamala in powdered form ( 30 capsules in every can ) , provided from herbal plants market and total microbial count te

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Taking one of SSRI drugs at least for one month , decreased libido after taking SSRI drugs , being married , consent

Exclusion criteria

Exclusion criteria: metabolic disorders , taking drugs such as anti-hypertension, anti-coagulant , anti-diabetic and cardiac pregnancy breastfeeding mothers

Design outcomes

Primary

Measure	Time frame
Libido. Timepoint: at begin and after 8 weeks. Method of measurement: Arizona questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarziye Bayat

Iran University of Medical Sciences

parisa.bayat9372@gmail.com+98 902 911 7290

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026